Haihe Biopharma

Developer of reformulations for cancer treatment

placePudong, Shanghai, China calendar_todayFounded 2012 groups181 employees language haihepharma.com

Innovation

25 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 273 times.

YearFilings
20161
20191
20202
20214
20226
202313
202414
20259
20264

Investor mix

22 investors on record; lead investors include Huagai Capital, Legend Capital, Warburg Pincus.

Investor typeCountShare
Venture capital627%
Private equity836%
Bank & private debt15%
Other / undisclosed732%
Coming soon